IMMUNABS
{{company.company_channel.channel_name}}
{{company.company_name_local}}
{{company.company_channel.channel_name}}
ImmunAbs Announces Conclusion of Phase 1 Clinical Trial, Revealing Positive Topline Results 2024-03-11 17:00
1